Literature DB >> 10609120

Diabetes mellitus in cystic fibrosis.

D S Hardin1, A Moran.   

Abstract

Glucose intolerance and diabetes are common complications of cystic fibrosis (CF), affecting up to 75% of the adult population. This article discusses the prevalence and pathophysiology of glucose tolerance abnormalities in CF, and reviews recent recommendations for diagnosis, screening, and management of CF-related diabetes (CFRD).

Entities:  

Mesh：

Year:  1999        PMID： 10609120     DOI： 10.1016/s0889-8529(05)70102-x

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN： 0889-8529            Impact factor:   4.741


  12 in total

Review 1.  The heart in cystic fibrosis.

Authors:  Rowland J Bright-Thomas; A Kevin Webb
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

Review 2.  Understanding cystic-fibrosis-related diabetes: best thought of as insulin deficiency?

Authors:  Lee Dobson; Christopher D Sheldon; Andrew T Hattersley
Journal:  J R Soc Med       Date:  2004       Impact factor: 5.344

3.  Routine OGTT screening for CFRD - no thanks.

Authors:  Martin Walshaw
Journal:  J R Soc Med       Date:  2009-07       Impact factor: 5.344

4.  Insulin production and resistance in cystic fibrosis: effect of age, disease activity, and genotype.

Authors:  M E Street; C Spaggiari; M A Ziveri; M Rossi; C Volta; I Viani; G L Grzincich; C Sartori; M Zanzucchi; V Raia; C Terzi; G Pisi; E Zanetti; M C S Boguszewski; T O Kamoi; S Bernasconi
Journal:  J Endocrinol Invest       Date:  2011-04-06       Impact factor: 4.256

5.  Insulin secretion abnormalities in exocrine pancreatic sufficient cystic fibrosis patients.

Authors:  Jamie L Wooldridge; Rhonda D Szczesniak; Matthew C Fenchel; Deborah A Elder
Journal:  J Cyst Fibros       Date:  2015-03-06       Impact factor: 5.482

Review 6.  Allergic bronchopulmonary aspergillosis.

Authors:  Richard B Moss
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

Review 7.  Diagnosis, screening, and management of cystic fibrosis-related diabetes.

Authors:  Antoinette Moran
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

8.  Hyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetes.

Authors:  William R Hunt; Susu M Zughaier; Dana E Guentert; Melissa A Shenep; Michael Koval; Nael A McCarty; Jason M Hansen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-10-04       Impact factor: 5.464

9.  Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.

Authors:  Thierry Ntimbane; Blandine Comte; Geneviève Mailhot; Yves Berthiaume; Vincent Poitout; Marc Prentki; Rémi Rabasa-Lhoret; Emile Levy
Journal:  Clin Biochem Rev       Date:  2009-11

10.  Insulin versus oral agents in the management of Cystic Fibrosis Related Diabetes: a case based study.

Authors:  Gary M Onady; Leora J Langdon
Journal:  BMC Endocr Disord       Date:  2006-06-21       Impact factor: 2.763
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.